A randomized, double blind, parallel, placebo‐controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children
Abstract In this clinical trial, the safety and effectiveness of Lactobacillus paracasei N1115 (LP N1115) were investigated as a potential probiotic to enhance gut development in young children born by caesarean section. Infants and young children between the ages of 6 months and 3 years were admini...
Guardado en:
Autores principales: | Shijie Wang, Yiping Xun, Grace J. Ahern, Lili Feng, Dong Zhang, Yuling Xue, Reynolds Paul Ross, Andrea M. Doolan, Catherine Stanton, Hong Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45391579f401486195328ef6c6f61917 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
por: Pu F, et al.
Publicado: (2017) -
Plant-Derived <i>Lactobacillus paracasei</i> IJH-SONE68 Improves Chronic Allergy Status: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Masafumi Noda, et al.
Publicado: (2021) -
THE PREBIOTIC POTENTIAL OF SOME CARBOHYDRATE SUBSTRATES ON THE GROWTH OF LACTOBACILLUS PLANTARUM AND LACTOBACILLUS RHAMNOSUS
por: Liliana LUCA, et al.
Publicado: (2019) -
Selenium nanoparticles from Lactobacillus paracasei HM1 capable of antagonizing animal pathogenic fungi as a new source from human breast milk
por: Mohamed T. El-Saadony, et al.
Publicado: (2021) -
Assessment of the feed additive consisting of Lacticaseibacillus paracasei (formerly Lactobacillus paracasei) DSM 16245 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG)
por: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Publicado: (2021)